ASCVD Risk Estimator Plus and PREVENT calculator would have classified many patients as low risk 48 hours before MI. (HealthDay News) — Population-based cardiac screening tools fail to identify many ...

Please provide your email address to receive an email when new articles are posted on . Long-term prediction tools can further discriminate a subgroup of young adults with elevated atherosclerotic CVD ...

Please provide your email address to receive an email when new articles are posted on . Those with stage 1 hypertension had lower 10-year ASCVD risk when estimated using new PREVENT equations. Use of ...

Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. Just over a year ago the ...

A risk calculator that incorporates established cardiovascular risk factors and additional cardiac biomarkers, such as high-sensitivity C-reactive protein (hs-CRP) and N-terminal pro-B-type ...

Panel (A) shows classifications based on the ASCVD Risk Estimator Plus, where 45% (209/465) of patients would not have qualified for statin therapy or further testing. Panel (B) displays results from ...

A retrospective study evaluated how risk- and symptom-based screening tools would have performed if applied 2 days before a patient's first heart attack. Many at-risk patients would have been missed ...

Estimates from the Predicting Risk of Cardiovascular Disease EVENT (PREVENT) equations identified substantially fewer individuals eligible to receive aspirin for the primary prevention of ...

More than 70% of people over 70 years old will one day develop cardiovascular disease, highlighting the need for effective diagnosis, treatment, and care for this population. Subscribe to our ...